Weekly Digest – January 2026 Weekly Digest – January 2026 26 December 2025: Junshi Biosciences EGFR-HER3 bispecific antibody ADC has successfully advanced to its global Phase 2 clinical trial, ranking second in the world Junshi Biosciences has recently registered a […]